XENE Xenon Corp Earnings per share for the last twelve months

Corporate emblem and logo of Xenon Pharmaceuticals Inc. (XENE)

Stable demand for epilepsy therapy creates a foundation for margin growth at Xenon Pharmaceuticals (XENE). The rolling annual earnings per share visualizes this trend, where -4.70 represents the latest level. High R&D costs and regulatory oversight limit competition, while a focus on internal development leads the company toward independent sales or the pursuit of a global partner.

Xenon Pharmaceuticals (XENE) - Earnings per share for the trailing year from 07/04/2022 to 11/17/2026

Analytical breakdowns for Xenon Pharmaceuticals Inc (XENE)

- current quotes and average value forecast:
Analysis of all company metrics:XENE - Xenon
Manufactured products of Xenon Pharmaceuticals Inc.

The stable operation of research facilities and adherence to testing schedules at Xenon Pharmaceuticals (XENE) create a foundation for capitalization, which is reflected in the trend of the fundamental trailing twelve months (TTM) earnings per share. This indicator calculates net income over a rolling year divided by the number of shares, allowing investors to assess the real equity value of the business and determine if the asset is overbought relative to its underlying yield.

Competing companies

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|VKTX - Net earnings per share for the trailing year|Net earnings per share for the last 12 months SUPN (supernus.com)|Net earnings per share for the last four quarters Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year HRMY|BHVN: Net earnings per share for the last 12 months|Earnings per share for the trailing year AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last twelve months Prothena Biosciences (PRTA)|Net earnings per share for the last four quarters Alector|Net earnings per share (EPS TTM) ANNX (annexonbio.com)|Earnings per share for the trailing year OMER|NGNE: Net earnings per share for the last 12 months|ACIU (AC Immune Corp) - Earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TVGN (Tevogen Bio)|Net earnings per share (EPS TTM) ACOG|CGTX - Net earnings per one share for the last twelve months|Inhibikase Pharma - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters cassavasciences.com (SAVA)|Assertio Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Coya Therapeutics COYA|VTGN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OVID|Earnings per share for the last twelve months Acumen Pharmaceuticals|CRVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATHE|CLNN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months PepGen Inc PEPG|Net earnings per share for the last four quarters jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ANVS (annovisbio.com)|Grace Tx (GRCE) - Earnings per share for the last twelve months|Firefly Neuroscience (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year